Italian technology plast / October 2024 |
Bormioli Pharma , an international leader in pharmaceutical packaging and medical devices , has presented an independent study demonstrating that bottles made with 100 % recycled , virgin-quality Loop™ PET resin contain zero extractables with toxicological relevance , making this plastic packaging solution one of the safest for pharmaceutical applications . The results of the independent research are extraordinary , confirming that bottles manufactured with Loop™ PET exceed the performance of bottles made from virgin PET which already guarantee full compliance with European Pharmacopoeia extractable limits by a margin of about 90 %. The research was conducted by the specialized laboratory Lab Analysis and commented on with a report by the Mario Veronesi Technopole Institute of Mirandola ( Modena , Italy ), part of the Democenter-Sipe Foundation , and represents a further breakthrough for the adoption of sustainable packaging in the pharmaceutical industry . “ The analysis has confirmed that the pharmaceutical packaging bottles manufactured with Loop™ PET resin represent today ’ s golden standard for the pharmaceutical industry from a safety point of view , in addition to environmental performance ” commented Andrea Lodetti , CEO of Bormioli Pharma . “ With even more pharma companies mentioning low-impact packaging targets in their Sustainability Reports , we are proud to make available a robust , premium-quality solution to facilitate the transition .” “ The complete and solid scientific tests that have been ran gave an unambiguous result : the bottles manufactured with Loop™ PET resin do not release any substance deemed of toxicological relevance , despite being exposed to a variety of extraction conditions , also including one worst-case scenario . For this reason , we can affirm that this material is a secure and reliable op- |
Bottles made with 100 % recycled , virgin-quality Loop™ PET resin
tion for pharmaceutical applications ” commented Professor Aldo Tomasi , Scientific Director of the Mario Veronesi Technopole Institute of Mirandola . “ The pharmaceutical industry demands the highest standards of safety and performance for their packaging solutions . The results of this study showcase the exceptional performance of our Loop™ PET and demonstrates that it surpasses the rigorous requirements of pharmaceutical packaging applications . By providing an innovative packaging solution and sustainable alternative to virgin PET that is reliable and ensures product safety , we are addressing the critical needs of the pharmaceutical industry ” commented Daniel Solomita , Founder and CEO of Loop Industries . The analysis was conducted using tools such as mass spectrometry and various solvents , with five different solutions ,
one of which was particularly aggressive - a 50 % isopropanol solution - to simulate the bottle ’ s performance under the most challenging environmental conditions , comparing the results with the requirements of the USP and European Pharmacopoeia . In 2023 , Bormioli Pharma reached a quota of 45 % low-impact materials in the products sold , getting closer and closer to the goal of 50 % by 2025 .
WORKING CLOSELY TO THE HEALTHCARE INDUSTRY Bormioli Pharma works closely with the pharmaceutical industry and all companies that are working towards the future of healthcare globally . As a world-renowned player in the packaging industry , the company serves the pharmaceutical and biopharmaceutical markets with complete solutions ,
|
including glass and plastic bottles , plastic and aluminum closures and accessories . Bormioli Pharma ’ s wide product ranges are designed and manufactured looking forward innovation and addressing ever-growing sustainability issues . Moreover , each product is specifically conceived for the destination market thanks to an accurate portfolio segmentation . Bormioli Pharma has a global presence in over 100 countries , with more than 1,400 employees and 9 plants across Europe specialized in the production of glass and plastic packaging . In 2023 , the company sold more than 8 billion pieces and reported annual sales exceeding 370 million euros . As a partner to the pharmaceutical industry , Bormioli Pharma invests and innovates with a single goal : making health a positive practice , available to everyone , kind to the planet . |
||
068 |
www . plastmagazine . it |